Merck & Co. MRK Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Merck & Co. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Merck & Co.'s other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Merck & Co.'s other accrued liabilities?
- Merck & Co. (MRK) reported other accrued liabilities of $14.55B in Q1 2026.
- How has Merck & Co.'s other accrued liabilities changed year-over-year?
- Merck & Co.'s other accrued liabilities increased by 13.9% year-over-year, from $12.77B to $14.55B.
- What is the long-term trend for Merck & Co.'s other accrued liabilities?
- Over 5 years (2020 to 2025), Merck & Co.'s other accrued liabilities has grown at a 3.4% compound annual growth rate (CAGR), from $12.21B to $14.47B.